Could this be the key to finally ending the threat of Ebola in the region? Uganda is taking a proactive stance against the deadly Ebola virus, launching a massive vaccination campaign aiming to immunize 25,000 people. This ambitious initiative comes as part of a larger strategy to combat the persistent threat of Ebola outbreaks in the region.
The Ugandan Ministry of Health has secured 25,000 doses of the Johnson & Johnson Ebola vaccine regimen, enough to fully vaccinate the targeted population. This two-dose vaccine, administered eight weeks apart, has been shown to provide long-lasting immunity.
The World Health Organization has prequalified the vaccine, and it has also received approval for use in Uganda from the National Drug Authority. The campaign will prioritize individuals considered most at risk, including;
Healthcare workers, armed forces personnel, refugees, immigration officers, traditional healers, and birth attendants. The vaccination drive will target 20 districts identified as high-risk areas for Ebola. These areas are primarily located in close proximity to the Congo Basin, a region with a history of Ebola outbreaks.
This proactive approach comes in response to the constant risk of the virus spreading across borders, as highlighted by the 2019 outbreak that reached the Democratic Republic of Congo. The first round of vaccinations began on September 23rd, 2024, with the second round scheduled for November 23rd, 2024.
The Ugandan government is committed to protecting its citizens and ensuring the health and safety of everyone within its borders. This vaccination drive represents a significant step towards that goal.
ALSO READ:Â President Yoweri Museveni Vows to ‘Crush’ Exploitative Money Lenders in Uganda
In a region grappling with the looming threat of Ebola, Uganda’s proactive vaccination campaign offers a beacon of hope. By prioritizing vulnerable populations and high-risk areas, the country aims to strengthen its defenses against the deadly virus and safeguard the health of its people.
